Global Valacyclovir Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Tablets

- Capsule

- Granules

Segment by Application

- Herpes Zoster Virus

- Herpes Simplex Virus

- EB Virus

- Cytomegalovirus

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- Mylan Pharmaceuticals

- Cobalt Laboratories (Allergan)

- Sorres Pharma

- Sivem Pharmaceuticals

- Remedy Repack

- Apotex Corporation

- Auro Pharma

- Biomed Pharma

- PLIVA

- Marcan Pharmaceuticals

- Jamp Pharma Corporatio

- Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

- Livzon Pharmaceutical Group

- Beijing Shuanglu Pharmaceutical

- Sichuan Mingxin Pharmaceutical

- Sichuan Baili Pharmaceutical

- Sichuan Kelun Pharmaceutical

- Ansi Pharmaceutical

- Yichang Dongyangguang Changjiang Pharmaceutical

- Shandong New Era Pharmaceutical

- Shandong Luoxin Pharmaceutical Group

- Guangdong Baike Pharmaceutical

- Chengdu Beite Pharmaceutical

- Kunming Yuanrui Pharmaceutical

- Yongxin Pharmaceutical Industry

- Hubei Huashitong Qianlong Pharmaceutical

- Hubei Yikang Pharmaceutical Factory

- Hubei Keyi Pharmaceutical

- Zhuhai Rundu Pharmaceutical

- Marcan Pharmaceuticals

- Jamp Pharma Corporatio

Global Valacyclovir Market Research Report 2022

Table of Contents
1 Valacyclovir Market Overview
1.1 Product Overview and Scope of Valacyclovir
1.2 Valacyclovir Segment by Type
1.2.1 Global Valacyclovir Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.3 Valacyclovir Segment by Application
1.3.1 Global Valacyclovir Sales Comparison by Application: (2022-2028)
1.3.2 Herpes Zoster Virus
1.3.3 Herpes Simplex Virus
1.3.4 EB Virus
1.3.5 Cytomegalovirus
1.4 Global Valacyclovir Market Size Estimates and Forecasts
1.4.1 Global Valacyclovir Revenue 2017-2028
1.4.2 Global Valacyclovir Sales 2017-2028
1.4.3 Valacyclovir Market Size by Region: 2017 Versus 2021 Versus 2028
2 Valacyclovir Market Competition by Manufacturers
2.1 Global Valacyclovir Sales Market Share by Manufacturers (2017-2022)
2.2 Global Valacyclovir Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Valacyclovir Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Valacyclovir Manufacturing Sites, Area Served, Product Type
2.5 Valacyclovir Market Competitive Situation and Trends
2.5.1 Valacyclovir Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Valacyclovir Players Market Share by Revenue
2.5.3 Global Valacyclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valacyclovir Retrospective Market Scenario by Region
3.1 Global Valacyclovir Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Valacyclovir Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Valacyclovir Market Facts & Figures by Country
3.3.1 North America Valacyclovir Sales by Country
3.3.2 North America Valacyclovir Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Valacyclovir Market Facts & Figures by Country
3.4.1 Europe Valacyclovir Sales by Country
3.4.2 Europe Valacyclovir Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Valacyclovir Market Facts & Figures by Region
3.5.1 Asia Pacific Valacyclovir Sales by Region
3.5.2 Asia Pacific Valacyclovir Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Valacyclovir Market Facts & Figures by Country
3.6.1 Latin America Valacyclovir Sales by Country
3.6.2 Latin America Valacyclovir Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Valacyclovir Market Facts & Figures by Country
3.7.1 Middle East and Africa Valacyclovir Sales by Country
3.7.2 Middle East and Africa Valacyclovir Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Valacyclovir Historic Market Analysis by Type
4.1 Global Valacyclovir Sales Market Share by Type (2017-2022)
4.2 Global Valacyclovir Revenue Market Share by Type (2017-2022)
4.3 Global Valacyclovir Price by Type (2017-2022)
5 Global Valacyclovir Historic Market Analysis by Application
5.1 Global Valacyclovir Sales Market Share by Application (2017-2022)
5.2 Global Valacyclovir Revenue Market Share by Application (2017-2022)
5.3 Global Valacyclovir Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GSK Valacyclovir Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Mylan Pharmaceuticals
6.2.1 Mylan Pharmaceuticals Corporation Information
6.2.2 Mylan Pharmaceuticals Description and Business Overview
6.2.3 Mylan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Mylan Pharmaceuticals Valacyclovir Product Portfolio
6.2.5 Mylan Pharmaceuticals Recent Developments/Updates
6.3 Cobalt Laboratories (Allergan)
6.3.1 Cobalt Laboratories (Allergan) Corporation Information
6.3.2 Cobalt Laboratories (Allergan) Description and Business Overview
6.3.3 Cobalt Laboratories (Allergan) Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Cobalt Laboratories (Allergan) Valacyclovir Product Portfolio
6.3.5 Cobalt Laboratories (Allergan) Recent Developments/Updates
6.4 Sorres Pharma
6.4.1 Sorres Pharma Corporation Information
6.4.2 Sorres Pharma Description and Business Overview
6.4.3 Sorres Pharma Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sorres Pharma Valacyclovir Product Portfolio
6.4.5 Sorres Pharma Recent Developments/Updates
6.5 Sivem Pharmaceuticals
6.5.1 Sivem Pharmaceuticals Corporation Information
6.5.2 Sivem Pharmaceuticals Description and Business Overview
6.5.3 Sivem Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sivem Pharmaceuticals Valacyclovir Product Portfolio
6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
6.6 Remedy Repack
6.6.1 Remedy Repack Corporation Information
6.6.2 Remedy Repack Description and Business Overview
6.6.3 Remedy Repack Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Remedy Repack Valacyclovir Product Portfolio
6.6.5 Remedy Repack Recent Developments/Updates
6.7 Apotex Corporation
6.6.1 Apotex Corporation Corporation Information
6.6.2 Apotex Corporation Description and Business Overview
6.6.3 Apotex Corporation Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Apotex Corporation Valacyclovir Product Portfolio
6.7.5 Apotex Corporation Recent Developments/Updates
6.8 Auro Pharma
6.8.1 Auro Pharma Corporation Information
6.8.2 Auro Pharma Description and Business Overview
6.8.3 Auro Pharma Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Auro Pharma Valacyclovir Product Portfolio
6.8.5 Auro Pharma Recent Developments/Updates
6.9 Biomed Pharma
6.9.1 Biomed Pharma Corporation Information
6.9.2 Biomed Pharma Description and Business Overview
6.9.3 Biomed Pharma Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Biomed Pharma Valacyclovir Product Portfolio
6.9.5 Biomed Pharma Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Corporation Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.10.4 PLIVA Valacyclovir Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Marcan Pharmaceuticals
6.11.1 Marcan Pharmaceuticals Corporation Information
6.11.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.11.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.11.5 Marcan Pharmaceuticals Recent Developments/Updates
6.12 Jamp Pharma Corporatio
6.12.1 Jamp Pharma Corporatio Corporation Information
6.12.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.12.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.12.5 Jamp Pharma Corporatio Recent Developments/Updates
6.13 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
6.13.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
6.13.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Description and Business Overview
6.13.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Product Portfolio
6.13.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
6.14 Livzon Pharmaceutical Group
6.14.1 Livzon Pharmaceutical Group Corporation Information
6.14.2 Livzon Pharmaceutical Group Valacyclovir Description and Business Overview
6.14.3 Livzon Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Livzon Pharmaceutical Group Valacyclovir Product Portfolio
6.14.5 Livzon Pharmaceutical Group Recent Developments/Updates
6.15 Beijing Shuanglu Pharmaceutical
6.15.1 Beijing Shuanglu Pharmaceutical Corporation Information
6.15.2 Beijing Shuanglu Pharmaceutical Valacyclovir Description and Business Overview
6.15.3 Beijing Shuanglu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Beijing Shuanglu Pharmaceutical Valacyclovir Product Portfolio
6.15.5 Beijing Shuanglu Pharmaceutical Recent Developments/Updates
6.16 Sichuan Mingxin Pharmaceutical
6.16.1 Sichuan Mingxin Pharmaceutical Corporation Information
6.16.2 Sichuan Mingxin Pharmaceutical Valacyclovir Description and Business Overview
6.16.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sichuan Mingxin Pharmaceutical Valacyclovir Product Portfolio
6.16.5 Sichuan Mingxin Pharmaceutical Recent Developments/Updates
6.17 Sichuan Baili Pharmaceutical
6.17.1 Sichuan Baili Pharmaceutical Corporation Information
6.17.2 Sichuan Baili Pharmaceutical Valacyclovir Description and Business Overview
6.17.3 Sichuan Baili Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Sichuan Baili Pharmaceutical Valacyclovir Product Portfolio
6.17.5 Sichuan Baili Pharmaceutical Recent Developments/Updates
6.18 Sichuan Kelun Pharmaceutical
6.18.1 Sichuan Kelun Pharmaceutical Corporation Information
6.18.2 Sichuan Kelun Pharmaceutical Valacyclovir Description and Business Overview
6.18.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sichuan Kelun Pharmaceutical Valacyclovir Product Portfolio
6.18.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.19 Ansi Pharmaceutical
6.19.1 Ansi Pharmaceutical Corporation Information
6.19.2 Ansi Pharmaceutical Valacyclovir Description and Business Overview
6.19.3 Ansi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Ansi Pharmaceutical Valacyclovir Product Portfolio
6.19.5 Ansi Pharmaceutical Recent Developments/Updates
6.20 Yichang Dongyangguang Changjiang Pharmaceutical
6.20.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
6.20.2 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Description and Business Overview
6.20.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Product Portfolio
6.20.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
6.21 Shandong New Era Pharmaceutical
6.21.1 Shandong New Era Pharmaceutical Corporation Information
6.21.2 Shandong New Era Pharmaceutical Valacyclovir Description and Business Overview
6.21.3 Shandong New Era Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Shandong New Era Pharmaceutical Valacyclovir Product Portfolio
6.21.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.22 Shandong Luoxin Pharmaceutical Group
6.22.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.22.2 Shandong Luoxin Pharmaceutical Group Valacyclovir Description and Business Overview
6.22.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Product Portfolio
6.22.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.23 Guangdong Baike Pharmaceutical
6.23.1 Guangdong Baike Pharmaceutical Corporation Information
6.23.2 Guangdong Baike Pharmaceutical Valacyclovir Description and Business Overview
6.23.3 Guangdong Baike Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Guangdong Baike Pharmaceutical Valacyclovir Product Portfolio
6.23.5 Guangdong Baike Pharmaceutical Recent Developments/Updates
6.24 Chengdu Beite Pharmaceutical
6.24.1 Chengdu Beite Pharmaceutical Corporation Information
6.24.2 Chengdu Beite Pharmaceutical Valacyclovir Description and Business Overview
6.24.3 Chengdu Beite Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Chengdu Beite Pharmaceutical Valacyclovir Product Portfolio
6.24.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
6.25 Kunming Yuanrui Pharmaceutical
6.25.1 Kunming Yuanrui Pharmaceutical Corporation Information
6.25.2 Kunming Yuanrui Pharmaceutical Valacyclovir Description and Business Overview
6.25.3 Kunming Yuanrui Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Kunming Yuanrui Pharmaceutical Valacyclovir Product Portfolio
6.25.5 Kunming Yuanrui Pharmaceutical Recent Developments/Updates
6.26 Yongxin Pharmaceutical Industry
6.26.1 Yongxin Pharmaceutical Industry Corporation Information
6.26.2 Yongxin Pharmaceutical Industry Valacyclovir Description and Business Overview
6.26.3 Yongxin Pharmaceutical Industry Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Yongxin Pharmaceutical Industry Valacyclovir Product Portfolio
6.26.5 Yongxin Pharmaceutical Industry Recent Developments/Updates
6.27 Hubei Huashitong Qianlong Pharmaceutical
6.27.1 Hubei Huashitong Qianlong Pharmaceutical Corporation Information
6.27.2 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Description and Business Overview
6.27.3 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Product Portfolio
6.27.5 Hubei Huashitong Qianlong Pharmaceutical Recent Developments/Updates
6.28 Hubei Yikang Pharmaceutical Factory
6.28.1 Hubei Yikang Pharmaceutical Factory Corporation Information
6.28.2 Hubei Yikang Pharmaceutical Factory Valacyclovir Description and Business Overview
6.28.3 Hubei Yikang Pharmaceutical Factory Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Hubei Yikang Pharmaceutical Factory Valacyclovir Product Portfolio
6.28.5 Hubei Yikang Pharmaceutical Factory Recent Developments/Updates
6.29 Hubei Keyi Pharmaceutical
6.29.1 Hubei Keyi Pharmaceutical Corporation Information
6.29.2 Hubei Keyi Pharmaceutical Valacyclovir Description and Business Overview
6.29.3 Hubei Keyi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.29.4 Hubei Keyi Pharmaceutical Valacyclovir Product Portfolio
6.29.5 Hubei Keyi Pharmaceutical Recent Developments/Updates
6.30 Zhuhai Rundu Pharmaceutical
6.30.1 Zhuhai Rundu Pharmaceutical Corporation Information
6.30.2 Zhuhai Rundu Pharmaceutical Valacyclovir Description and Business Overview
6.30.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.30.4 Zhuhai Rundu Pharmaceutical Valacyclovir Product Portfolio
6.30.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
6.31 Marcan Pharmaceuticals
6.31.1 Marcan Pharmaceuticals Corporation Information
6.31.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.31.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.31.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.31.5 Marcan Pharmaceuticals Recent Developments/Updates
6.32 Jamp Pharma Corporatio
6.32.1 Jamp Pharma Corporatio Corporation Information
6.32.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.32.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2017-2022)
6.32.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.32.5 Jamp Pharma Corporatio Recent Developments/Updates
7 Valacyclovir Manufacturing Cost Analysis
7.1 Valacyclovir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Valacyclovir
7.4 Valacyclovir Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Valacyclovir Distributors List
8.3 Valacyclovir Customers
9 Valacyclovir Market Dynamics
9.1 Valacyclovir Industry Trends
9.2 Valacyclovir Market Drivers
9.3 Valacyclovir Market Challenges
9.4 Valacyclovir Market Restraints
10 Global Market Forecast
10.1 Valacyclovir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Valacyclovir by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Valacyclovir by Type (2023-2028)
10.2 Valacyclovir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Valacyclovir by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Valacyclovir by Application (2023-2028)
10.3 Valacyclovir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Valacyclovir by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Valacyclovir by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Valacyclovir Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Valacyclovir Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Valacyclovir Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Valacyclovir Market Competitive Situation by Manufacturers in 2021
Table 5. Global Valacyclovir Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Valacyclovir Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Valacyclovir Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Valacyclovir Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Valacyclovir Average Price (US$/G) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Valacyclovir Manufacturing Sites and Area Served
Table 11. Manufacturers Valacyclovir Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Valacyclovir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valacyclovir as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Valacyclovir Sales by Region (2017-2022) & (KG)
Table 16. Global Valacyclovir Sales Market Share by Region (2017-2022)
Table 17. Global Valacyclovir Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Valacyclovir Revenue Market Share by Region (2017-2022)
Table 19. North America Valacyclovir Sales by Country (2017-2022) & (KG)
Table 20. North America Valacyclovir Sales Market Share by Country (2017-2022)
Table 21. North America Valacyclovir Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Valacyclovir Revenue Market Share by Country (2017-2022)
Table 23. Europe Valacyclovir Sales by Country (2017-2022) & (KG)
Table 24. Europe Valacyclovir Sales Market Share by Country (2017-2022)
Table 25. Europe Valacyclovir Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Valacyclovir Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Valacyclovir Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Valacyclovir Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Valacyclovir Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Valacyclovir Revenue Market Share by Region (2017-2022)
Table 31. Latin America Valacyclovir Sales by Country (2017-2022) & (KG)
Table 32. Latin America Valacyclovir Sales Market Share by Country (2017-2022)
Table 33. Latin America Valacyclovir Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Valacyclovir Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Valacyclovir Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Valacyclovir Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Valacyclovir Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Valacyclovir Revenue Market Share by Country (2017-2022)
Table 39. Global Valacyclovir Sales by Type (2017-2022) & (KG)
Table 40. Global Valacyclovir Sales Market Share by Type (2017-2022)
Table 41. Global Valacyclovir Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Valacyclovir Revenue Share by Type (2017-2022)
Table 43. Global Valacyclovir Price by Type (2017-2022) & (US$/G)
Table 44. Global Valacyclovir Sales (KG) by Application (2017-2022)
Table 45. Global Valacyclovir Sales Market Share by Application (2017-2022)
Table 46. Global Valacyclovir Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Valacyclovir Revenue Share by Application (2017-2022)
Table 48. Global Valacyclovir Price by Application (2017-2022) & (US$/G)
Table 49. GSK Corporation Information
Table 50. GSK Description and Business Overview
Table 51. GSK Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 52. GSK Valacyclovir Product
Table 53. GSK Recent Developments/Updates
Table 54. Mylan Pharmaceuticals Corporation Information
Table 55. Mylan Pharmaceuticals Description and Business Overview
Table 56. Mylan Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 57. Mylan Pharmaceuticals Valacyclovir Product
Table 58. Mylan Pharmaceuticals Recent Developments/Updates
Table 59. Cobalt Laboratories (Allergan) Corporation Information
Table 60. Cobalt Laboratories (Allergan) Description and Business Overview
Table 61. Cobalt Laboratories (Allergan) Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 62. Cobalt Laboratories (Allergan) Valacyclovir Product
Table 63. Cobalt Laboratories (Allergan) Recent Developments/Updates
Table 64. Sorres Pharma Corporation Information
Table 65. Sorres Pharma Description and Business Overview
Table 66. Sorres Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 67. Sorres Pharma Valacyclovir Product
Table 68. Sorres Pharma Recent Developments/Updates
Table 69. Sivem Pharmaceuticals Corporation Information
Table 70. Sivem Pharmaceuticals Description and Business Overview
Table 71. Sivem Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 72. Sivem Pharmaceuticals Valacyclovir Product
Table 73. Sivem Pharmaceuticals Recent Developments/Updates
Table 74. Remedy Repack Corporation Information
Table 75. Remedy Repack Description and Business Overview
Table 76. Remedy Repack Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 77. Remedy Repack Valacyclovir Product
Table 78. Remedy Repack Recent Developments/Updates
Table 79. Apotex Corporation Corporation Information
Table 80. Apotex Corporation Description and Business Overview
Table 81. Apotex Corporation Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 82. Apotex Corporation Valacyclovir Product
Table 83. Apotex Corporation Recent Developments/Updates
Table 84. Auro Pharma Corporation Information
Table 85. Auro Pharma Description and Business Overview
Table 86. Auro Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 87. Auro Pharma Valacyclovir Product
Table 88. Auro Pharma Recent Developments/Updates
Table 89. Biomed Pharma Corporation Information
Table 90. Biomed Pharma Description and Business Overview
Table 91. Biomed Pharma Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 92. Biomed Pharma Valacyclovir Product
Table 93. Biomed Pharma Recent Developments/Updates
Table 94. PLIVA Corporation Information
Table 95. PLIVA Description and Business Overview
Table 96. PLIVA Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 97. PLIVA Valacyclovir Product
Table 98. PLIVA Recent Developments/Updates
Table 99. Marcan Pharmaceuticals Corporation Information
Table 100. Marcan Pharmaceuticals Description and Business Overview
Table 101. Marcan Pharmaceuticals Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 102. Marcan Pharmaceuticals Valacyclovir Product
Table 103. Marcan Pharmaceuticals Recent Developments/Updates
Table 104. Jamp Pharma Corporatio Corporation Information
Table 105. Jamp Pharma Corporatio Description and Business Overview
Table 106. Jamp Pharma Corporatio Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 107. Jamp Pharma Corporatio Valacyclovir Product
Table 108. Jamp Pharma Corporatio Recent Developments/Updates
Table 109. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
Table 110. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
Table 111. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 112. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Product
Table 113. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
Table 114. Livzon Pharmaceutical Group Corporation Information
Table 115. Livzon Pharmaceutical Group Description and Business Overview
Table 116. Livzon Pharmaceutical Group Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 117. Livzon Pharmaceutical Group Valacyclovir Product
Table 118. Livzon Pharmaceutical Group Recent Developments/Updates
Table 119. Beijing Shuanglu Pharmaceutical Corporation Information
Table 120. Beijing Shuanglu Pharmaceutical Description and Business Overview
Table 121. Beijing Shuanglu Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 122. Beijing Shuanglu Pharmaceutical Valacyclovir Product
Table 123. Beijing Shuanglu Pharmaceutical Recent Developments/Updates
Table 124. Sichuan Mingxin Pharmaceutical Corporation Information
Table 125. Sichuan Mingxin Pharmaceutical Description and Business Overview
Table 126. Sichuan Mingxin Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 127. Sichuan Mingxin Pharmaceutical Valacyclovir Product
Table 128. Sichuan Mingxin Pharmaceutical Recent Developments/Updates
Table 129. Sichuan Baili Pharmaceutical Corporation Information
Table 130. Sichuan Baili Pharmaceutical Description and Business Overview
Table 131. Sichuan Baili Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 132. Sichuan Baili Pharmaceutical Valacyclovir Product
Table 133. Sichuan Baili Pharmaceutical Recent Developments/Updates
Table 134. Sichuan Kelun Pharmaceutical Corporation Information
Table 135. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 136. Sichuan Kelun Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 137. Sichuan Kelun Pharmaceutical Valacyclovir Product
Table 138. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 139. Ansi Pharmaceutical Corporation Information
Table 140. Ansi Pharmaceutical Description and Business Overview
Table 141. Ansi Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 142. Ansi Pharmaceutical Valacyclovir Product
Table 143. Ansi Pharmaceutical Recent Developments/Updates
Table 144. Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
Table 145. Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
Table 146. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 147. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Product
Table 148. Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
Table 149. Shandong New Era Pharmaceutical Corporation Information
Table 150. Shandong New Era Pharmaceutical Description and Business Overview
Table 151. Shandong New Era Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 152. Shandong New Era Pharmaceutical Valacyclovir Product
Table 153. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 154. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 155. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 156. Shandong Luoxin Pharmaceutical Group Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 157. Shandong Luoxin Pharmaceutical Group Valacyclovir Product
Table 158. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
Table 159. Guangdong Baike Pharmaceutical Corporation Information
Table 160. Guangdong Baike Pharmaceutical Description and Business Overview
Table 161. Guangdong Baike Pharmaceutical Valacyclovir Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 162. Guangdong Baike Pharmaceutical Valacyclovir Product
Table 163. Guangdong Baike Pharmaceutical Recent Developments/Updates
T
  • Global Tenosynovitis Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Tenosynovitis Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tenosynovitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Nonsteroidal Anti-inflammatory Drugs (NSAIDs) - Antibiotics - Corticos......
  • Global Ephedrine Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 71
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Capsule - Injection Segment by Application - Bronchial Asthma - Other......
  • Global Woman Disease Pharmaceutical Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 95
    Woman Disease Pharmaceutical market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Woman Disease Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - OTC - Prescription Segment by Application......
  • Global Zinc Oxide Bandages Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Zinc Oxide 10% - Zinc Oxide 20% - Others Segment by Application - Orthopedic -......
  • Global Vinca Alkaloids Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 86
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oncovin - Velban - Navelbine Segment by Application - Lymphoma - Sarcoma......
  • Global Vitamin C Chewable Tablet Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 106
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Fruit Flavour - Other Segment by Application - Adult - Elderly - Children......
  • Global Central Nervous System (CNS) Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Central Nervous System (CNS) Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Prescription Drugs - OTC Segment b......
  • Global Liver Supplement Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 102
    Liver Supplement market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Liver Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Tablets - Capsules - Others Segment by Application - O......
  • Global Cancer Medication Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 90
    Cancer Medication market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Antimetabolite - Alkaloid Drugs - Hormone - Targeted Drug - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs